666752-18-7 Usage
General Description
(5-bromo-3-methyl-1H-indol-2-yl)methanol is a chemical compound with the molecular formula C10H10BrNO. It is a member of the indole family of organic compounds, which are commonly found in nature and have diverse biological activities. This specific compound is a derivative of indole and contains a bromine atom and a methyl group. It is used in organic synthesis and pharmaceutical research, as well as in the development of new drugs and agrochemicals. The bromo and methyl groups present in the molecule can impact its reactivity and biological properties, making it a potentially valuable building block for the synthesis of new compounds with desired pharmacological and chemical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 666752-18-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,6,7,5 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 666752-18:
(8*6)+(7*6)+(6*6)+(5*7)+(4*5)+(3*2)+(2*1)+(1*8)=197
197 % 10 = 7
So 666752-18-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H10BrNO/c1-6-8-4-7(11)2-3-9(8)12-10(6)5-13/h2-4,12-13H,5H2,1H3
666752-18-7Relevant articles and documents
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
-
Page/Page column 21-22, (2008/06/13)
Novel compounds useful as chemotherapeutic and chemopreventive agents are provided. The compounds are analogs of indole-3-carbinol metabolites wherein the structures and substituents of the compounds are selected to enhance the compounds' overall efficacy, particularly with respect to therapeutic activity, oral bioavailability, long-term safety, patient tolerability, and therapeutic window. The compounds are useful not only in treatment of cancer but also in prevention of cancer. One preferred class of the novel compounds have the structure of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, and R12 are defined herein. Pharmaceutical compositions are provided as well, as are methods of synthesis and use.
